Centessa Pharmaceuticals chief business officer sells shares worth $193,429
Gregory M. Weinhoff, the Chief Business Officer of Centessa Pharmaceuticals plc (NASDAQ:CNTA), a $2.16 billion market cap ...
manilatimes57m
Knight Therapeutics and Helsinn Healthcare SA Expand Relationship and Enter into Exclusive License, Distribution, and Supply Agreement for Onicit®
Knight and Helsinn had entered into an exclusive license, distribution and supply agreement for AKYNZEO ® oral/IV (netupitant/palonosetron / fosnetupitant/palonosetron) in Canada, Brazil, Argentina, ...